SWM
MRTX

Sanctuary Wealth Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sanctuary Wealth Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$176 – 306
2023
Q4 		$176 Hold
3
– – ﹤0.01% 279
2023
Q3 		$131 Hold
3
– – ﹤0.01% 278
2023
Q2 		$108 Buy
+3
New +$124 ﹤0.01% 286
2022
Q4 		$136 Buy
+3
New +$194 ﹤0.01% 270

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sanctuary Wealth Management's MRTX Position: Q1 2024 in Review

Sanctuary Wealth Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 3 shares — an estimated $176 sold.

Sanctuary Wealth Management first reported a position in MRTX in Q4 2022 and held it in 4 quarters. The position peaked at $176 in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Sanctuary Wealth Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Sanctuary Wealth Management sold 3 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $176.
  • Sanctuary Wealth Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Sanctuary Wealth Management's Mirati Therapeutics, Inc. Common Stock position peaked at $176 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Sanctuary Wealth Management's 13F filing for Q1 2024, filed 7 May 2024.